Causal associations between genetically predicted placental weight and migraine
Abstract
Background: Placental weight (PW) is a crucial factor in fetal development, influencing various health outcomes throughout life. This study investigates whether there is a causal relationship between PW and the risk of developing migraine.
Methods: Genetic variants associated with PW were obtained from the Early Growth Genetics Consortium, including fetal, maternal, and paternal genomes. Migraine data were derived from a 2022 genome-wide association study meta-analysis by the International Headache Genetics Consortium. Significant single nucleotide polymorphisms (SNPs) associated with PW were selected and analyzed to assess causality.
Results: Out of 11 PW phenotypes, six PW phenotypes with at least two SNPs each were included for Mendelian randomization analysis. The analysis revealed that PW (fetal effect, conditional on maternal and paternal genotype) was significantly associated with a reduced risk of migraine (odds ratio 0.81, 95% confidence interval 0.71-0.93; p = 0.003, false discovery rate adjusted p = 0.018). Sensitivity analyses confirmed the robustness of the findings, showing no evidence of heterogeneity or pleiotropy.
Conclusion: Our findings suggest a potential causal relationship between fetal genetically predicted increased PW and a reduced risk of migraine in the offspring. Further research into the mechanisms underlying this association and its implications for migraine prevention is warranted.
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.